Aseptika Shortlisted for Three Upcoming Innovation Awards

The first is the Cambridge News Top Innovations awards, secondly the Discovery Start-up 2014 Competition run by Cambridge Wireless and the third recently announced is the Hunts Post Huntingdonshire Business Innovation Awards 2014. These nominations recognise Aseptika’s innovative respiratory hospital-at-home solution and biomarker test, which is currently running as the SENSOR clinical trial with a group of volunteer patients that suffer from COPD or severe Asthma in the Portsmouth area. Dr. Kevin Auton, Managing Director of Aseptika Limited, commented: “We are honoured to be short-listed for these awards and especially considering the high standard and innovation of the other UK SME companies also shortlisted.”